Form 4: Iradimed Director Anthony Vuoto Receives Restricted Stock Units

Director Anthony Vuoto of Iradimed Corporation received 1,811 restricted stock units under the company's 2023 Equity Incentive Plan.

Summary

• Anthony Vuoto, a director at Iradimed Corporation, was granted 1,811 restricted stock units.
• These units were awarded under the company's 2023 Equity Incentive Plan.
• The restricted stock units will vest in two equal annual installments, starting on December 11, 2025.
• Upon vesting, each unit will convert into one share of Iradimed common stock.
• Following this transaction, Mr. Vuoto beneficially owns 3,008 shares of common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine grant of stock units, which is generally positive for aligning director interests, but not a major event.

Positives

• The grant of restricted stock units aligns the director's interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Future Outlook

The restricted stock units will vest in two equal annual installments starting December 11, 2025, converting into common stock.

Industry Context

This is a standard practice for incentivizing directors and aligning their interests with the company's long-term performance.

Comparison to Industry Standards

• Granting restricted stock units to directors is a common practice across many publicly traded companies.
• The vesting schedule of two years is also a typical approach to ensure long-term alignment.
• Many companies in the medical device sector, such as Medtronic and Stryker, use similar equity-based compensation plans for their directors.

Stakeholder Impact

• Shareholders may view this as a positive sign of aligning director interests with company performance.
• The grant of restricted stock units does not have a direct impact on employees, customers, suppliers, or creditors.

Next Steps

• The restricted stock units will vest in two equal annual installments starting December 11, 2025.

Key Dates

Keywords

restricted stock units, equity incentive plan, insider trading, beneficial ownership, Iradimed, IRMD, Anthony Vuoto